SCHEMBL25530571

SCHEMBL25530571

CCN(Cc1ccc(C(C)(C)C)cc1OC(F)(F)F)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A4 P31645 2/20 0.34
HTR2A P28223 1/20 0.34
KCNH2 Q12809 1/20 0.34
SLC6A3 Q01959 2/20 0.33
SLC6A2 P23975 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
CYP2D6 P10635 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
EPHX2 P34913 1/20 0.30
NR1H4 Q96RI1 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
CETP P11597 1/20 0.30
DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25530577 0.84 CYP1A2 (0.41) CYP1A2CYP2C19KDM4EHSP90AA1HSP90AB1
SCHEMBL25530560 0.83 ADRA2A (0.39) CYP1A2CYP2C19SLC6A4HTR2AKCNH2
SCHEMBL25536709 0.81 CYP1A2 (0.37) CYP1A2CYP2C19SLC6A4HTR2AKCNH2
SCHEMBL25574716 0.81 CA1 (0.40) CYP1A2CYP2C19KDM4EHSP90AA1HSP90AB1
SCHEMBL25530566 0.78 CYP1A2 (0.41) CYP1A2CYP2C19SLC6A4SLC6A2KDM4E
SCHEMBL25530581 0.78 CYP1A2 (0.44) CYP1A2CYP2C19SLC6A4SLC6A3SLC6A2
SCHEMBL25530564 0.75 CYP2C19 (0.44) CYP1A2CYP2C19KDM4EHSP90AA1HSP90AB1
SCHEMBL25530569 0.72 HTR2A (0.37) CYP1A2CYP2C19SLC6A4HTR2AKCNH2
SCHEMBL15803005 0.69 KDM4E (0.40) KDM4ECA1CA2CA9EPHX2
SCHEMBL10064792 0.69 PDE2A (0.41) KCNH2CA1CA2CA9EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159491-A1 Antimicrobial Compounds and Methods MPO, NISCH, RPN2 CYP1A2 3539/4885CYP2C19 2355/4885SLC6A4 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.